+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

THU0237Disease Activity in Patients with Juvenile Spondyloarthropathy on anti-TNF Therapy as Measured by The Juvenile Arthritis Disease Activity Score (JADAS)-10 and The Juvenile Spondyloarthritis Disease Activity Index (JSPADA)



THU0237Disease Activity in Patients with Juvenile Spondyloarthropathy on anti-TNF Therapy as Measured by The Juvenile Arthritis Disease Activity Score (JADAS)-10 and The Juvenile Spondyloarthritis Disease Activity Index (JSPADA)



Annals of the Rheumatic Diseases 75(Suppl 2): 273.3-274




(PDF emailed within 0-6 h: $19.90)

Accession: 064924258

Download citation: RISBibTeXText

DOI: 10.1136/annrheumdis-2016-eular.3223


Related references

FRI0330Development of cut-off values for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score (JADAS):. Annals of the Rheumatic Diseases 71(Suppl 3): 425.3-426, 2013

Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis. Rheumatology 53(2): 307-312, 2014

Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Arthritis and Rheumatism 64(7): 2366-2374, 2012

Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. Arthritis Care and Research 66(11): 1703-1709, 2014

Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 75(3): 635-636, 2016

Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score. Annals of the Rheumatic Diseases 73(7): 1380-1383, 2014

Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 77(3): 336-342, 2017

Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study. Rheumatology 55(4): 615-623, 2016

C-reactive protein in the assessment of disease activity in juvenile rheumatoid arthritis and juvenile spondyloarthritis. Scandinavian Journal of Rheumatology 16(2): 101-105, 1987

Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 72(12): 1983-1988, 2014

Comparison of the Disease Activity Score-28 and Juvenile Arthritis Disease Activity Score in the juvenile idiopathic arthritis. Revista Brasileira de Reumatologia 55(1): 31-36, 2017

Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity score. Rheumatology 53(7): 1229-1234, 2014

Correlation of rheumatoid arthritis activity indexes (Disease Activity Score 28 measured with ESR and CRP, Simplified Disease Activity Index and Clinical Disease Activity Index) and agreement of disease activity states with various cut-off points in a Northeastern Brazilian population. Revista Brasileira de Reumatologia 55(6): 477-484, 2018

Prospective validation of the Juvenile Spondyloarthritis Disease Activity Index in children with enthesitis-related arthritis. Rheumatology 57(12): 2167-2171, 2018

AB0908Evaluation of the Activity of Juvenile Idiopathic Arthritis by Jadas: Jadas ESR versus Jadas3. Annals of the Rheumatic Diseases 73(Suppl 2): 1101.1-1101, 2014